Sintx Technologies (SINT) Competitors $3.27 +0.19 (+6.17%) Closing price 04:00 PM EasternExtended Trading$3.10 -0.17 (-5.20%) As of 07:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SINT vs. OSRH, LYRA, NXL, FEMY, QTI, ALUR, RVP, CLGN, NRXS, and PETVShould you be buying Sintx Technologies stock or one of its competitors? The main competitors of Sintx Technologies include OSR (OSRH), Lyra Therapeutics (LYRA), Nexalin Technology (NXL), Femasys (FEMY), QT Imaging (QTI), Allurion Technologies (ALUR), Retractable Technologies (RVP), CollPlant Biotechnologies (CLGN), NeurAxis (NRXS), and PetVivo (PETV). These companies are all part of the "medical equipment" industry. Sintx Technologies vs. Its Competitors OSR Lyra Therapeutics Nexalin Technology Femasys QT Imaging Allurion Technologies Retractable Technologies CollPlant Biotechnologies NeurAxis PetVivo Sintx Technologies (NASDAQ:SINT) and OSR (NASDAQ:OSRH) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, community ranking, earnings, valuation, profitability, dividends, media sentiment and institutional ownership. Do analysts recommend SINT or OSRH? Sintx Technologies presently has a consensus price target of $28.00, indicating a potential upside of 756.27%. Given Sintx Technologies' stronger consensus rating and higher possible upside, equities research analysts plainly believe Sintx Technologies is more favorable than OSR.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sintx Technologies 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00OSR 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has more volatility & risk, SINT or OSRH? Sintx Technologies has a beta of 0.73, suggesting that its stock price is 27% less volatile than the S&P 500. Comparatively, OSR has a beta of 1.61, suggesting that its stock price is 61% more volatile than the S&P 500. Does the MarketBeat Community believe in SINT or OSRH? Sintx Technologies received 38 more outperform votes than OSR when rated by MarketBeat users. CompanyUnderperformOutperformSintx TechnologiesOutperform Votes3861.29% Underperform Votes2438.71% OSRN/AN/A Which has better earnings and valuation, SINT or OSRH? OSR has lower revenue, but higher earnings than Sintx Technologies. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSintx Technologies$1.23M6.68-$8.26M-$50.56-0.06OSR-$148.95K-182.48N/AN/AN/A Is SINT or OSRH more profitable? OSR has a net margin of 0.00% compared to Sintx Technologies' net margin of -358.79%. OSR's return on equity of 0.00% beat Sintx Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Sintx Technologies-358.79% -140.68% -78.29% OSR N/A N/A N/A Do insiders & institutionals believe in SINT or OSRH? 18.4% of Sintx Technologies shares are owned by institutional investors. Comparatively, 55.3% of OSR shares are owned by institutional investors. 0.0% of Sintx Technologies shares are owned by insiders. Comparatively, 33.7% of OSR shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Does the media prefer SINT or OSRH? In the previous week, Sintx Technologies had 2 more articles in the media than OSR. MarketBeat recorded 3 mentions for Sintx Technologies and 1 mentions for OSR. OSR's average media sentiment score of 1.87 beat Sintx Technologies' score of 0.43 indicating that OSR is being referred to more favorably in the news media. Company Overall Sentiment Sintx Technologies Neutral OSR Very Positive SummarySintx Technologies and OSR tied by winning 7 of the 14 factors compared between the two stocks. Get Sintx Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for SINT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SINT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SINT vs. The Competition Export to ExcelMetricSintx TechnologiesSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$8.20M$4.32B$5.56B$8.50BDividend YieldN/A42.67%5.28%4.16%P/E Ratio-0.0627.8226.6419.64Price / Sales6.6868.18407.99152.17Price / CashN/A51.0838.2534.64Price / Book0.015.746.974.60Net Income-$8.26M$66.95M$3.23B$248.06M7 Day Performance15.14%-2.95%-0.98%-1.03%1 Month Performance-1.21%14.68%7.70%3.50%1 Year Performance-30.87%17.75%31.32%12.68% Sintx Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SINTSintx Technologies2.1699 of 5 stars$3.27+6.2%$28.00+756.3%-35.3%$8.20M$1.23M-0.0640Short Interest ↑OSRHOSRN/A$1.45+6.6%N/AN/A$27.95M-$148.95K0.00N/APositive NewsGap DownLYRALyra Therapeutics3.0428 of 5 stars$18.42-24.1%$100.00+442.9%-23.5%$24.41M$1.19M-12.3650Positive NewsShort Interest ↓Analyst RevisionGap DownHigh Trading VolumeNXLNexalin Technology2.3362 of 5 stars$1.27-1.6%$5.00+293.7%+94.5%$21.82M$131.07K-1.983FEMYFemasys3.0678 of 5 stars$0.80flat$8.67+983.3%-11.1%$21.79M$1.70M-0.9930News CoverageAnalyst ForecastQTIQT ImagingN/A$0.79+0.6%N/A+2.5%$21.44M$4.00M0.00N/AGap UpALURAllurion Technologies3.4584 of 5 stars$2.75+2.1%$22.83+731.5%-92.6%$20.48M$28.30M-0.23501Positive NewsShort Interest ↓Gap DownRVPRetractable Technologies1.2466 of 5 stars$0.67+0.1%N/A-39.6%$19.94M$33.75M-1.23240Gap DownCLGNCollPlant Biotechnologies2.7125 of 5 stars$1.73-10.8%$11.50+564.7%-67.1%$19.82M$2.47M-1.1270High Trading VolumeNRXSNeurAxis0.9426 of 5 stars$2.66+1.9%N/A-21.5%$19.20M$2.93M-1.4519Short Interest ↑Gap UpPETVPetVivoN/A$0.75-3.8%N/A+9.5%$18.21M$1.05M-1.6720Gap Up Related Companies and Tools Related Companies OSRH Alternatives LYRA Alternatives NXL Alternatives FEMY Alternatives QTI Alternatives ALUR Alternatives RVP Alternatives CLGN Alternatives NRXS Alternatives PETV Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SINT) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sintx Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sintx Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SINT Stock Free SINT Stock Alerts